---
schema_version: "secwatch.filing_event.v1"
accession: "0001599298-24-000040"
form_type: "8-K"
ticker: "SMMT"
cik: "0001599298"
company_name: "Summit Therapeutics Inc."
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T23:01:45.726393+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Summit Therapeutics presents at Barclays conference; no new material disclosed in filing excerpt

## Summary
- Presentation slides made available on March 12, 2024 at Barclays Global Healthcare Conference.
- Speakers listed: Dr. Maky Zanganeh (CEO & President) and Bob Duggan (Chairman & CEO).
- No specific pipeline updates, financial data, or clinical results provided in the filed exhibit.

## SEC filing metadata
- accession: 0001599298-24-000040
- form_type: 8-K
- ticker: SMMT
- cik: 0001599298
- company_name: Summit Therapeutics Inc.
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000040/0001599298-24-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000040/smmt-20240312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001599298-24-000040
- JSON: https://secwatch.observer/filing/0001599298-24-000040.json
- Plain text: https://secwatch.observer/filing/0001599298-24-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
